genetic medicine
HIMSS25
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.
The collaboration will leverage Genetic Leap's RNA-targeted AI platform to create genetic medicines against selected targets.